Combined HR suggested that BCR-ABL1 isoforms did not significantly affect the OS of patients with Ph+ ALL (HR = 1.15, 95% CI 0.92–1.45) (Fig 2B). Here, BCR is linked to acute lymphoblastic leukemia.